Search

Your search keyword '"Castelletti S"' showing total 285 results

Search Constraints

Start Over You searched for: Author "Castelletti S" Remove constraint Author: "Castelletti S"
285 results on '"Castelletti S"'

Search Results

1. Candidacy and long-term outcomes of subcutaneous implantable cardioverter-defibrillators in current practice in patients with hypertrophic cardiomyopathy

2. Candidacy and long-term outcomes of subcutaneous implantable cardioverter-defibrillators in current practice in patients with hypertrophic cardiomyopathy

3. Standardised assessment of evidence supporting the adoption of mobile health solutions: A Clinical Consensus Statement of the ESC Regulatory Affairs Committee

4. From the phenotype to precision medicine: An update on the cardiomyopathies diagnostic workflow

5. Corrigendum to “Molecular genetic testing in athletes: Why and when a position statement from the Italian Society of Sports Cardiology” [International Journal of Cardiology Volume 364, 1 October 2022, Pages 169–177]. (International Journal of Cardiology (2022) 364 (169–177), (S016752732200818X), (10.1016/j.ijcard.2022.05.071))

7. Left Cardiac Sympathetic Denervation for Long QT Syndrome: 50 Years’ Experience Provides Guidance for Management

12. Use of artificial intelligence to automatically predict the optimal patient-specific inversion time for late gadolinium enhancement imaging. Tool development and clinical validation

13. Circadian and Seasonal Pattern of Arrhythmic Events in Arrhythmogenic Cardiomyopathy Patients

14. Improved diagnostic accuracy for apical hypertrophic cardiomyopathy

15. Left Cardiac Sympathetic Denervation for Long QT Syndrome: 50 Years’ Experience Provides Guidance for Management

16. Estimating the Posttest Probability of Long QT Syndrome Diagnosis for Rare KCNH2 Variants

17. Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls

18. Mutation location and IKsregulation in the arrhythmic risk of long QT syndrome type 1: The importance of the KCNQ1 S6 region

19. Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort

20. A Primary Prevention Clinical Risk Score Model for Patients With Brugada Syndrome (BRUGADA-RISK)

22. SCN5A mutation type and a genetic risk score associate variably with brugada syndrome phenotype in SCN5A families

23. Abnormal myocardial expression of SAP97 is associated with arrhythmogenic risk

24. Partial Pericardial Agenesis Mimicking Arrhythmogenic Right Ventricular Cardiomyopathy

25. Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy

26. Indications and utility of cardiac genetic testing in athletes

27. Author Correction: Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility (Nature Genetics, (2022), 54, 3, (232-239), 10.1038/s41588-021-01007-6)

28. Molecular genetic testing in athletes: Why and when a position statement from the Italian Society of Sports Cardiology

29. Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility

30. Indications and utility of cardiac genetic testing in athletes

31. Effective Study: Development and Application of a Question-Driven, Time-Effective Cardiac Magnetic Resonance Scanning Protocol

32. Prevalence and outcomes of WPW pattern in the young: a report from a nationwide cardiac screening programme

35. Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data

36. Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data

37. Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls

38. Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort

39. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

40. Long and Short QT syndromes.

41. Exercise Training-Induced Repolarization Abnormalities Masquerading as Congenital Long QT Syndrome

44. The Membership Committee of the ESC

45. Risk score for the exclusion of arrhythmic events in arrhythmogenic right ventricular cardiomyopathy at first presentation

46. Topografie a confronto: Piuro 1618 – 2018

47. From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2

48. L'Italia come modello per l'Europa e per il mondo nelle politiche sanitarie per il trattamento dell'epatite cronica da HCV

49. DSP 突变与致心律失常性心肌病

50. DSP mutations and arrhythmogenic cardiomyopathy

Catalog

Books, media, physical & digital resources